Liu et al.v.Wizel et al.

Patent Trial and Appeal Board

Sep 28, 2012

11690036 (P.T.A.B. Sep. 28, 2012)

Mail Stop Interference Paper 30
P.O. Box 1450 Entered: September 28, 2012
Alexandria Va 22313-1450
Tel: 571-272-9797
Fax: 571-273-0042

UNITED STATES PATENT AND TRADEMARK OFFICE
_______________

BEFORE THE PATENT TRIAL AND APPEAL BOARD
_______________

Amgen, Inc.,
Junior Party
(Application 11/690,036,
Inventors: Belle B. Liu, Pengzu Zhou, and Nina Cauchon),

v.

Teva Pharmaceutical Industries Ltd. &
Teva Pharmaceuticals USA, Inc.,
Senior Party
(Patent 7,563,930
Inventors: Shlomit Wizel, Revital Lifshitz-Liron, and
Sharon Avhar-Maydan).

Patent Interference 105,832 (RES)
(Technology Center 1600)

Before FRED E. McKELVEY, RICHARD E. SCHAFER, and
RICHARD TORCZON, Administrative Patent Judges.

SCHAFER, Administrative Patent Judge.

Judgment - Request for Adverse - 37 CFR § 41.127(b)
2

Amgen, the common assignee of Application 11/690,036 and 1
Patent 7,563,930, requests that adverse judgment be entered against the patent. 2
Paper 29. 3
Accordingly , it is 4
ORDERED that judgment on priority as to the subject matter of Count 1 5
(Paper 1, p. 4) is awarded against Patent 7,563,930; 6
FURTHER ORDERED that claims 1-31 and 37 (corresponding to 7
Count 1) of Patent 7,563,930 shall be cancelled (35 U.S.C. § 135(a)); 8
FURTHER ORDERED that a copy of this judgment be made of record in 9
the files of Patent 7,563,930 and Application 11/690,036; 10
FURTHER ORDERED that if there is any settlement agreement or related 11
documents which have not been filed, attention is directed to 35 U.S.C. § 135(c) 12
and 37 CFR § 41.205. 13
14
cc (electronic delivery):

Amgen, Inc.
Anthony M. Zupcic, Esq
Daniel S. Glueck, Esq.
Fitzpatrick, Cella, Harper & Scinto
azupcic@fchs.com
dglueck@fchs.com

Courtesy copy:

Steven J. Lee, Esq.
Patrick J. Birdie, Esq.
Kenyon & Kenyon
Email: slee@kenyon.com
Email: pbirdie@kenyon.com